Indole: A privileged scaffold for the design of anti-cancer agents.
Identifieur interne : 000885 ( PubMed/Checkpoint ); précédent : 000884; suivant : 000886Indole: A privileged scaffold for the design of anti-cancer agents.
Auteurs : Yichao Wan [République populaire de Chine] ; Yuanhua Li [République populaire de Chine] ; Chunxing Yan [République populaire de Chine] ; Mi Yan [République populaire de Chine] ; Zilong Tang [République populaire de Chine]Source :
- European journal of medicinal chemistry [ 1768-3254 ] ; 2019.
Descripteurs français
- KwdFr :
- Antinéoplasiques (), Antinéoplasiques (pharmacologie), Antinéoplasiques (synthèse chimique), Conception de médicament, Humains, Indoles (), Indoles (pharmacologie), Indoles (synthèse chimique), Protéine Mcl-1 (antagonistes et inhibiteurs), Protéine Mcl-1 (métabolisme), Protéines proto-oncogènes c-pim-1 (antagonistes et inhibiteurs), Protéines proto-oncogènes c-pim-1 (métabolisme), Tests de criblage d'agents antitumoraux, Tubuline (métabolisme), Tumeurs (métabolisme), Tumeurs (traitement médicamenteux).
- MESH :
- antagonistes et inhibiteurs : Protéine Mcl-1, Protéines proto-oncogènes c-pim-1.
- métabolisme : Protéine Mcl-1, Protéines proto-oncogènes c-pim-1, Tubuline, Tumeurs.
- pharmacologie : Antinéoplasiques, Indoles.
- synthèse chimique : Antinéoplasiques, Indoles.
- traitement médicamenteux : Tumeurs.
- Antinéoplasiques, Conception de médicament, Humains, Indoles, Tests de criblage d'agents antitumoraux.
English descriptors
- KwdEn :
- Antineoplastic Agents (chemical synthesis), Antineoplastic Agents (chemistry), Antineoplastic Agents (pharmacology), Drug Design, Drug Screening Assays, Antitumor, Humans, Indoles (chemical synthesis), Indoles (chemistry), Indoles (pharmacology), Myeloid Cell Leukemia Sequence 1 Protein (antagonists & inhibitors), Myeloid Cell Leukemia Sequence 1 Protein (metabolism), Neoplasms (drug therapy), Neoplasms (metabolism), Proto-Oncogene Proteins c-pim-1 (antagonists & inhibitors), Proto-Oncogene Proteins c-pim-1 (metabolism), Tubulin (metabolism).
- MESH :
- chemical , antagonists & inhibitors : Myeloid Cell Leukemia Sequence 1 Protein, Proto-Oncogene Proteins c-pim-1.
- chemical , chemical synthesis : Antineoplastic Agents, Indoles.
- chemical , chemistry : Antineoplastic Agents, Indoles.
- chemical , metabolism : Myeloid Cell Leukemia Sequence 1 Protein, Proto-Oncogene Proteins c-pim-1, Tubulin.
- chemical , pharmacology : Antineoplastic Agents, Indoles.
- drug therapy : Neoplasms.
- metabolism : Neoplasms.
- Drug Design, Drug Screening Assays, Antitumor, Humans.
Abstract
In general, heterocyclic compounds are a significant source of pharmacologically active compounds. Among them, the indole scaffold widely distributes in natural products and bioactive molecules including anti-cancer agents. In view of its unique physic-chemical and biological properties, it has been used as a privileged scaffold in the anti-cancer agents design. So far, many natural and synthetic indole derivatives have been discovered as promising anti-cancer agents used in clinic or clinical evaluations, suggesting its prominent place in anti-cancer drugs development. This review aimed to provide a clear knowledge on the recent development of indoles as anti-cancer agents, such as myeloid cell leukemia-1 (Mcl-1) inhibitors, proviral insertion site in moloney murine leukemia virus (Pim) inhibitors, histone deacetylase (HDAC) inhibitors, silent mating type information regulation 2 homolog (SIRT) inhibitors and tubulin inhibitors, and made an insight into the corresponding structure-activity relationships (SARs). We hope the review could give a guide to develop new anti-cancer agents with greater potency against drug-sensitive and drug-resistant cancers in the future.
DOI: 10.1016/j.ejmech.2019.111691
PubMed: 31536895
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:31536895Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Indole: A privileged scaffold for the design of anti-cancer agents.</title><author><name sortKey="Wan, Yichao" sort="Wan, Yichao" uniqKey="Wan Y" first="Yichao" last="Wan">Yichao Wan</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China. Electronic address: 07wanyichao@hnust.edu.cn.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author><author><name sortKey="Li, Yuanhua" sort="Li, Yuanhua" uniqKey="Li Y" first="Yuanhua" last="Li">Yuanhua Li</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author><author><name sortKey="Yan, Chunxing" sort="Yan, Chunxing" uniqKey="Yan C" first="Chunxing" last="Yan">Chunxing Yan</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author><author><name sortKey="Yan, Mi" sort="Yan, Mi" uniqKey="Yan M" first="Mi" last="Yan">Mi Yan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, The Second Hospital of Shandong University, Jinan, Shandong, 250033, PR China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, The Second Hospital of Shandong University, Jinan, Shandong, 250033</wicri:regionArea><wicri:noRegion>250033</wicri:noRegion></affiliation></author><author><name sortKey="Tang, Zilong" sort="Tang, Zilong" uniqKey="Tang Z" first="Zilong" last="Tang">Zilong Tang</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China. Electronic address: zltang@hnust.edu.cn.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31536895</idno><idno type="pmid">31536895</idno><idno type="doi">10.1016/j.ejmech.2019.111691</idno><idno type="wicri:Area/PubMed/Corpus">000872</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000872</idno><idno type="wicri:Area/PubMed/Curation">000872</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000872</idno><idno type="wicri:Area/PubMed/Checkpoint">000885</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000885</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Indole: A privileged scaffold for the design of anti-cancer agents.</title><author><name sortKey="Wan, Yichao" sort="Wan, Yichao" uniqKey="Wan Y" first="Yichao" last="Wan">Yichao Wan</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China. Electronic address: 07wanyichao@hnust.edu.cn.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author><author><name sortKey="Li, Yuanhua" sort="Li, Yuanhua" uniqKey="Li Y" first="Yuanhua" last="Li">Yuanhua Li</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author><author><name sortKey="Yan, Chunxing" sort="Yan, Chunxing" uniqKey="Yan C" first="Chunxing" last="Yan">Chunxing Yan</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author><author><name sortKey="Yan, Mi" sort="Yan, Mi" uniqKey="Yan M" first="Mi" last="Yan">Mi Yan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacy, The Second Hospital of Shandong University, Jinan, Shandong, 250033, PR China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, The Second Hospital of Shandong University, Jinan, Shandong, 250033</wicri:regionArea><wicri:noRegion>250033</wicri:noRegion></affiliation></author><author><name sortKey="Tang, Zilong" sort="Tang, Zilong" uniqKey="Tang Z" first="Zilong" last="Tang">Zilong Tang</name><affiliation wicri:level="1"><nlm:affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China. Electronic address: zltang@hnust.edu.cn.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201</wicri:regionArea><wicri:noRegion>411201</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of medicinal chemistry</title><idno type="eISSN">1768-3254</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (chemical synthesis)</term><term>Antineoplastic Agents (chemistry)</term><term>Antineoplastic Agents (pharmacology)</term><term>Drug Design</term><term>Drug Screening Assays, Antitumor</term><term>Humans</term><term>Indoles (chemical synthesis)</term><term>Indoles (chemistry)</term><term>Indoles (pharmacology)</term><term>Myeloid Cell Leukemia Sequence 1 Protein (antagonists & inhibitors)</term><term>Myeloid Cell Leukemia Sequence 1 Protein (metabolism)</term><term>Neoplasms (drug therapy)</term><term>Neoplasms (metabolism)</term><term>Proto-Oncogene Proteins c-pim-1 (antagonists & inhibitors)</term><term>Proto-Oncogene Proteins c-pim-1 (metabolism)</term><term>Tubulin (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques ()</term><term>Antinéoplasiques (pharmacologie)</term><term>Antinéoplasiques (synthèse chimique)</term><term>Conception de médicament</term><term>Humains</term><term>Indoles ()</term><term>Indoles (pharmacologie)</term><term>Indoles (synthèse chimique)</term><term>Protéine Mcl-1 (antagonistes et inhibiteurs)</term><term>Protéine Mcl-1 (métabolisme)</term><term>Protéines proto-oncogènes c-pim-1 (antagonistes et inhibiteurs)</term><term>Protéines proto-oncogènes c-pim-1 (métabolisme)</term><term>Tests de criblage d'agents antitumoraux</term><term>Tubuline (métabolisme)</term><term>Tumeurs (métabolisme)</term><term>Tumeurs (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Myeloid Cell Leukemia Sequence 1 Protein</term><term>Proto-Oncogene Proteins c-pim-1</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antineoplastic Agents</term><term>Indoles</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antineoplastic Agents</term><term>Indoles</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Myeloid Cell Leukemia Sequence 1 Protein</term><term>Proto-Oncogene Proteins c-pim-1</term><term>Tubulin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antineoplastic Agents</term><term>Indoles</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéine Mcl-1</term><term>Protéines proto-oncogènes c-pim-1</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Protéine Mcl-1</term><term>Protéines proto-oncogènes c-pim-1</term><term>Tubuline</term><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antinéoplasiques</term><term>Indoles</term></keywords><keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antinéoplasiques</term><term>Indoles</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Design</term><term>Drug Screening Assays, Antitumor</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Antinéoplasiques</term><term>Conception de médicament</term><term>Humains</term><term>Indoles</term><term>Tests de criblage d'agents antitumoraux</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In general, heterocyclic compounds are a significant source of pharmacologically active compounds. Among them, the indole scaffold widely distributes in natural products and bioactive molecules including anti-cancer agents. In view of its unique physic-chemical and biological properties, it has been used as a privileged scaffold in the anti-cancer agents design. So far, many natural and synthetic indole derivatives have been discovered as promising anti-cancer agents used in clinic or clinical evaluations, suggesting its prominent place in anti-cancer drugs development. This review aimed to provide a clear knowledge on the recent development of indoles as anti-cancer agents, such as myeloid cell leukemia-1 (Mcl-1) inhibitors, proviral insertion site in moloney murine leukemia virus (Pim) inhibitors, histone deacetylase (HDAC) inhibitors, silent mating type information regulation 2 homolog (SIRT) inhibitors and tubulin inhibitors, and made an insight into the corresponding structure-activity relationships (SARs). We hope the review could give a guide to develop new anti-cancer agents with greater potency against drug-sensitive and drug-resistant cancers in the future.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31536895</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1768-3254</ISSN><JournalIssue CitedMedium="Internet"><Volume>183</Volume><PubDate><Year>2019</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of medicinal chemistry</Title><ISOAbbreviation>Eur J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Indole: A privileged scaffold for the design of anti-cancer agents.</ArticleTitle><Pagination><MedlinePgn>111691</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0223-5234(19)30841-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmech.2019.111691</ELocationID><Abstract><AbstractText>In general, heterocyclic compounds are a significant source of pharmacologically active compounds. Among them, the indole scaffold widely distributes in natural products and bioactive molecules including anti-cancer agents. In view of its unique physic-chemical and biological properties, it has been used as a privileged scaffold in the anti-cancer agents design. So far, many natural and synthetic indole derivatives have been discovered as promising anti-cancer agents used in clinic or clinical evaluations, suggesting its prominent place in anti-cancer drugs development. This review aimed to provide a clear knowledge on the recent development of indoles as anti-cancer agents, such as myeloid cell leukemia-1 (Mcl-1) inhibitors, proviral insertion site in moloney murine leukemia virus (Pim) inhibitors, histone deacetylase (HDAC) inhibitors, silent mating type information regulation 2 homolog (SIRT) inhibitors and tubulin inhibitors, and made an insight into the corresponding structure-activity relationships (SARs). We hope the review could give a guide to develop new anti-cancer agents with greater potency against drug-sensitive and drug-resistant cancers in the future.</AbstractText><CopyrightInformation>Copyright © 2019 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Yichao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China. Electronic address: 07wanyichao@hnust.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Chunxing</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Mi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, The Second Hospital of Shandong University, Jinan, Shandong, 250033, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Zilong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China; Hunan Provincial College Key Laboratory of QSAR/QSPR, Hunan Provincial Key Lab of Advanced Materials for New Energy Storage and Conversion, Hunan University of Science and Technology, Xiangtan, Hunan, 411201, PR China. Electronic address: zltang@hnust.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Med Chem</MedlineTA><NlmUniqueID>0420510</NlmUniqueID><ISSNLinking>0223-5234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579095">MCL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064549">Myeloid Cell Leukemia Sequence 1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014404">Tubulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>8724FJW4M5</RegistryNumber><NameOfSubstance UI="C030374">indole</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051573">Proto-Oncogene Proteins c-pim-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015195" MajorTopicYN="Y">Drug Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004354" MajorTopicYN="N">Drug Screening Assays, Antitumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064549" MajorTopicYN="N">Myeloid Cell Leukemia Sequence 1 Protein</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051573" MajorTopicYN="N">Proto-Oncogene Proteins c-pim-1</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-Cancer</Keyword><Keyword MajorTopicYN="N">Drug design</Keyword><Keyword MajorTopicYN="N">Indole</Keyword><Keyword MajorTopicYN="N">Structure-activity relationships</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>07</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>09</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31536895</ArticleId><ArticleId IdType="pii">S0223-5234(19)30841-4</ArticleId><ArticleId IdType="doi">10.1016/j.ejmech.2019.111691</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Wan, Yichao" sort="Wan, Yichao" uniqKey="Wan Y" first="Yichao" last="Wan">Yichao Wan</name></noRegion><name sortKey="Li, Yuanhua" sort="Li, Yuanhua" uniqKey="Li Y" first="Yuanhua" last="Li">Yuanhua Li</name><name sortKey="Tang, Zilong" sort="Tang, Zilong" uniqKey="Tang Z" first="Zilong" last="Tang">Zilong Tang</name><name sortKey="Yan, Chunxing" sort="Yan, Chunxing" uniqKey="Yan C" first="Chunxing" last="Yan">Chunxing Yan</name><name sortKey="Yan, Mi" sort="Yan, Mi" uniqKey="Yan M" first="Mi" last="Yan">Mi Yan</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000885 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000885 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:31536895
|texte= Indole: A privileged scaffold for the design of anti-cancer agents.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:31536895" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |